The Bottom Fishing Club - Simulations Plus: Huge Potential In AI Drug Discovery
Source: SeekingAlpha
2025-09-22 00:00:09 ET
A smaller-cap pick that has reached for an ultra-low valuation in recent months is Simulations Plus, Inc. ( SLP ). The company has run a drug discovery and research computer-modeling firm for many years, with decent growth rates and mild profitability. Honestly, that's enough positivity for me to get interested in the stock....
Read the full article on Seeking Alpha
For further details see:
The Bottom Fishing Club - Simulations Plus: Huge Potential In AI Drug Discovery
Simulations Plus Inc.
NASDAQ: SLP
SLP Trading
-1.91% G/L:
$12.055 Last:
86,932 Volume:
$12.35 Open:
SLP Latest News
March 03, 2026 07:55:00 am
Simulations Plus Convenes Industry and Regulatory Leaders to Define Responsible AI in MIDD
February 09, 2026 06:45:00 pm
Simulations Plus Announces Extensions of U.S. FDA and NIEHS Research Collaborations
January 21, 2026 04:05:00 pm
Simulations Plus Highlights Platform Innovation and Strategic Direction at 2026 Investor Day
SLP Stock Data
$281,347,060
16,298,587
16.67%
64
N/A
Healthcare Providers & Services
Healthcare
US
Research Triangle Park
